Qiming U.S. Ventures Management, LLC Activity Q4 2021-Q3 2023

Q3 2023
 Value Shares↓ Weighting
SellVENTYX BIOSCIENCES INC$23,837,630
-2.6%
686,370
-8.0%
31.65%
+23.0%
Q2 2023
 Value Shares↓ Weighting
NewICOSAVAX INC$34,856,5643,510,22836.63%
NewVENTYX BIOSCIENCES INC$24,480,936746,37025.72%
NewJASPER THERAPEUTICS INC$11,671,9188,519,64812.26%
NewHILLEVAX INC$9,607,886558,92310.10%
TALS NewTALARIS THERAPEUTICS INC$8,915,1222,932,6069.37%
ELEV NewELEVATION ONCOLOGY INC$3,602,6162,370,1423.79%
KZR NewKEZAR LIFE SCIENCES INC$2,030,342828,7112.13%
Q4 2022
 Value Shares↓ Weighting
ELEV ExitELEVATION ONCOLOGY INC$0-2,370,142-3.89%
ExitJASPER THERAPEUTICS INC$0-5,852,982-6.71%
KZR ExitKEZAR LIFE SCIENCES INC$0-828,711-10.36%
TALS ExitTALARIS THERAPEUTICS INC$0-2,932,606-11.20%
ExitHILLEVAX INC$0-558,923-13.88%
ExitICOSAVAX INC$0-3,510,228-16.11%
ExitVENTYX BIOSCIENCES INC$0-746,370-37.85%
Q3 2022
 Value Shares↓ Weighting
SellVENTYX BIOSCIENCES INC$26,056,000
+134.0%
746,370
-18.0%
37.85%
+144.9%
Q2 2022
 Value Shares↓ Weighting
NewICOSAVAX INC$20,114,0003,510,22827.92%
TALS NewTALARIS THERAPEUTICS INC$13,226,0002,932,60618.36%
NewJASPER THERAPEUTICS INC$11,296,0005,852,98215.68%
NewVENTYX BIOSCIENCES INC$11,133,000910,30615.45%
KZR NewKEZAR LIFE SCIENCES INC$6,853,000828,7119.51%
NewHILLEVAX INC$6,109,000558,9238.48%
ELEV NewELEVATION ONCOLOGY INC$3,318,0002,370,1424.60%

Export Qiming U.S. Ventures Management, LLC's holdings